Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Championing nurse-led services for cardiology patients.

Pottle, Alison.

Br J Nurs ; 33(1): 44-45, 2024 Jan 11.

Artigo em Inglês | MEDLINE | ID: mdl-38194335

2.

Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial.

Khan, Tina Z; Hsu, Li-Yueh; Arai, Andrew E; Rhodes, Samantha; Pottle, Alison; Wage, Ricardo; Banya, Winston; Gatehouse, Peter D; Giri, Shivraman; Collins, Peter; Pennell, Dudley J; Barbir, Mahmoud.

Eur Heart J ; 38(20): 1561-1569, 2017 May 21.

Artigo em Inglês | MEDLINE | ID: mdl-28453721

3.

Mindfulness-based intervention in patients with persistent pain in chest (MIPIC) of non-cardiac cause: a feasibility randomised control study.

Mittal, Tarun Kumar; Evans, Emma; Pottle, Alison; Lambropoulos, Costas; Morris, Charlotte; Surawy, Christina; Chuter, Antony; Cox, Felicia; de Silva, Ranil; Mason, Mark; Banya, Winston; Thakrar, Diviash; Tyrer, Peter.

Open Heart ; 9(1)2022 05.

Artigo em Inglês | MEDLINE | ID: mdl-35545356

4.

Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom.

Reynolds, Timothy Mark; Pottle, Alison; Quoraishi, Sadat H.

Vasc Health Risk Manag ; 17: 227-237, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-34054297

5.

Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.

Iqbal, Zohaib; Ho, Jan Hoong; Adam, Safwaan; France, Michael; Syed, Akheel; Neely, Dermot; Rees, Alan; Khatib, Rani; Cegla, Jaimini; Byrne, Christopher; Qureshi, Nadeem; Capps, Nigel; Ferns, Gordon; Payne, Jules; Schofield, Jonathan; Nicholson, Kirsty; Datta, Dev; Pottle, Alison; Halcox, Julian; Krentz, Andrew; Durrington, Paul; Soran, Handrean.

Atherosclerosis ; 313: 126-136, 2020 11.

Artigo em Inglês | MEDLINE | ID: mdl-33045618

6.

Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial.

Khan, Tina Z; Gorog, Diana A; Arachchillage, Deepa J; Ahnström, Josefin; Rhodes, Samantha; Donovan, Jacqueline; Banya, Winston; Pottle, Alison; Barbir, Mahmoud; Pennell, Dudley J.

J Clin Lipidol ; 13(5): 788-796, 2019.

Artigo em Inglês | MEDLINE | ID: mdl-31353231

7.

Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.

Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Nath Datta, Dev Borunendra.

Atherosclerosis ; 290: 44-51, 2019 11.

Artigo em Inglês | MEDLINE | ID: mdl-31563836

8.

Reflection on the development of the nurse consultant role.

Pottle, Alison.

Nurs Stand ; 2018 Aug 30.

Artigo em Inglês | MEDLINE | ID: mdl-30160836

9.

Vascular access in lipoprotein apheresis: a retrospective analysis from the UK's largest lipoprotein apheresis centre.

Doherty, Daniel J; Pottle, Alison; Malietzis, George; Hakim, Nadey; Barbir, Mahmoud; Crane, Jeremy S.

J Vasc Access ; 19(1): 52-57, 2018 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-29076516

10.

Measuring cholesterol levels.

Pottle, Alison.

Nurs Stand ; 21(46): 42-7, 2007.

Artigo em Inglês | MEDLINE | ID: mdl-17711246

11.

Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score.

Mittal, Tarun K; Pottle, Alison; Nicol, Ed; Barbir, Mahmoud; Ariff, Ben; Mirsadraee, Saeed; Dubowitz, Michael; Gorog, Diana A; Clifford, Piers; Firoozan, Soroosh; Smith, Robert; Dubrey, Simon; Chana, Harmeet; Shah, Jaymin; Stephens, Nigel; Travill, Christopher; Kelion, Andrew; Pakkal, Mini; Timmis, Adam.

Eur Heart J Cardiovasc Imaging ; 18(8): 922-929, 2017 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-28379388

12.

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.

France, Michael; Rees, Alan; Datta, Dev; Thompson, Gilbert; Capps, Nigel; Ferns, Gordon; Ramaswami, Uma; Seed, Mary; Neely, Dermot; Cramb, Robert; Shoulders, Carol; Barbir, Mahmoud; Pottle, Alison; Eatough, Ruth; Martin, Steven; Bayly, Graham; Simpson, Bill; Halcox, Julian; Edwards, Ray; Main, Linda; Payne, Jules; Soran, Handrean.

Atherosclerosis ; 255: 128-139, 2016 12.

Artigo em Inglês | MEDLINE | ID: mdl-27839699

13.

Familial hypercholesterolaemia: clinical features and management.

Pottle, Alison.

Nurs Stand ; 20(14-16): 55-65; quiz 66, 2005.

Artigo em Inglês | MEDLINE | ID: mdl-16372559

14.

Prevalence and patterns of cognitive impairment in acute coronary syndrome patients: A systematic review.

Pottle, Alison.

Eur J Prev Cardiol ; 27(3): 281-283, 2020 02.

Artigo em Inglês | MEDLINE | ID: mdl-31791145

15.

The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial.

Khan, Tina Z; Pottle, Alison; Pennell, Dudley J; Barbir, Mahmoud S.

Atheroscler Suppl ; 18: 103-8, 2015 May.

Artigo em Inglês | MEDLINE | ID: mdl-25936312

16.

High prevalence of raised lipoprotein(a) in patients with refractory angina.

Khan, Tina Z; Rhodes, Samantha; Pottle, Alison; Banya, Winston; Smith, Robert; Kabir, Tito; Ilsley, Charles; Pennell, Dudley J; Barbir, Mahmoud.

Glob Cardiol Sci Pract ; 2015(2): 28, 2015.

Artigo em Inglês | MEDLINE | ID: mdl-26779510

17.

Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51].

Pottle, Alison; Thompson, Gilbert; Barbir, Mahmoud; Bayly, Graham; Cegla, Jaimini; Cramb, Robert; Dawson, Tina; Eatough, Ruth; Kale, Vaishali; Neuwirth, Clare; Nicholson, Kirsty; Payne, Jules; Scott, James; Soran, Handrean; Walji, Shahenaz; Watkins, Suzanne; Weedon, Hazel; Datta, Dev Borunendra Nath.

Atherosclerosis ; 294: 16, 2020 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-31935635

18.

The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.

Khan, Tina Z; Pottle, Alison; Pennell, Dudley J; Barbir, Mahmoud S.

Glob Cardiol Sci Pract ; 2014(1): 3-12, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-25054114

19.

Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease.

Ibrahim, Michael; Ussen, Bassey; Pottle, Alison; Barbir, Mahmoud.

J Clin Lipidol ; 6(2): 192-4, 2012.

Artigo em Inglês | MEDLINE | ID: mdl-22385553

20.

Combating high cholesterol. Interview by Ann Shuttleworth.

Pottle, Alison.

Nurs Times ; 102(50): 20-1, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-17212291

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Championing nurse-led services for cardiology patients.

Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial.

Mindfulness-based intervention in patients with persistent pain in chest (MIPIC) of non-cardiac cause: a feasibility randomised control study.

Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom.

Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.

Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial.

Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.

Reflection on the development of the nurse consultant role.

Vascular access in lipoprotein apheresis: a retrospective analysis from the UK's largest lipoprotein apheresis centre.

Measuring cholesterol levels.

Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score.

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.

Familial hypercholesterolaemia: clinical features and management.

Prevalence and patterns of cognitive impairment in acute coronary syndrome patients: A systematic review.

The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial.

High prevalence of raised lipoprotein(a) in patients with refractory angina.

Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51].

The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.

Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease.

Combating high cholesterol. Interview by Ann Shuttleworth.